Cipher Pharmaceuticals Inc.
CPHRF
$11.14
$0.34063.15%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 11.34M | 22.00M | 17.84M | 9.52M | 47.98M |
Total Receivables | 11.87M | 11.77M | 13.86M | 13.22M | 3.78M |
Inventory | 5.58M | 5.54M | 5.79M | 5.27M | 2.90M |
Prepaid Expenses | 1.77M | 837.00K | 995.00K | 1.05M | 301.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 30.55M | 40.15M | 38.48M | 29.06M | 54.96M |
|
|||||
Total Current Assets | 30.55M | 40.15M | 38.48M | 29.06M | 54.96M |
Net Property, Plant & Equipment | 522.00K | 602.00K | 680.00K | 853.00K | 369.00K |
Long-term Investments | 17.45M | 17.45M | 17.45M | 15.71M | 15.71M |
Goodwill | 17.45M | 17.45M | 17.45M | 15.71M | 15.71M |
Total Other Intangibles | 75.29M | 77.01M | 78.75M | 85.97M | 1.24M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 28.59M | 27.87M | 27.15M | 22.27M | 21.63M |
Total Assets | 152.39M | 163.07M | 162.51M | 153.86M | 93.91M |
|
|||||
Total Accounts Payable | 4.85M | 5.30M | 5.87M | 5.46M | 4.31M |
Total Accrued Expenses | 82.00K | 330.00K | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 262.00K | 267.00K | 283.00K | 263.00K | 96.00K |
Total Finance Division Other Current Liabilities | 12.57M | 11.69M | 13.72M | 8.78M | 510.00K |
Total Other Current Liabilities | 12.57M | 11.69M | 13.72M | 8.78M | 510.00K |
Total Current Liabilities | 17.76M | 17.59M | 19.87M | 14.51M | 4.91M |
|
|||||
Total Current Liabilities | 17.76M | 17.59M | 19.87M | 14.51M | 4.91M |
Long-Term Debt | 25.00M | 40.00M | 40.00M | 40.00M | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 193.00K | 245.00K | 295.00K | 489.00K | 200.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 42.96M | 57.83M | 60.17M | 55.00M | 5.11M |
|
|||||
Common Stock & APIC | 34.71M | 34.48M | 34.21M | 34.06M | 24.29M |
Retained Earnings | 84.25M | 80.28M | 77.65M | 74.31M | 74.03M |
Treasury Stock & Other | -9.51M | -9.51M | -9.51M | -9.51M | -9.51M |
Total Common Equity | 109.44M | 105.24M | 102.34M | 98.86M | 88.80M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 109.44M | 105.24M | 102.34M | 98.86M | 88.80M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 109.44M | 105.24M | 102.34M | 98.86M | 88.80M |
|